Comparative pharmacology and toxicology of tramadol and tapentadol

• Type: Another Publication in an International Scientific Journal
• Date: 2018

Authors

Faria, J (Author) Other; Barbosa, J (Author) Other; Moreira, R (Author) Other; Queiros, O (Author) Other; Felix Carvalho (Author) FFUP; Dinis Oliveira, RJ (Author) Other

Journal

Title: European Journal of Pain

Vol. 22

Pages: 827-844

ISSN: 1090-3801

Publisher: Wiley-Blackwell

Indexing

ISI Web of Knowledge - 54 Citations

Scopus - 63 Citations

Other information

Authenticus ID: P-00N-X8K

DOI: 10.1002/ejp.1196

Abstract (EN): Moderate-to-severe pain represents a heavy burden in patients' quality of life, and ultimately in the society and in healthcare costs. The aim of this review was to summarize data on tramadol and tapentadol adverse effects, toxicity, potential advantages and limitations according to the context of clinical use. We compared data on the pharmacological and toxicological profiles of tramadol and tapentadol, after an extensive literature search in the US National Library of Medicine (PubMed). Tramadol is a prodrug that acts through noradrenaline and serotonin reuptake inhibition, with a weak opioid component added by its metabolite O-desmethyltramadol. Tapentadol does not require metabolic activation and acts mainly through noradrenaline reuptake inhibition and has a strong opioid activity. Such features confer tapentadol potential advantages, namely lower serotonergic, dependence and abuse potential, more linear pharmacokinetics, greater gastrointestinal tolerability and applicability in the treatment of chronic and neuropathic pain. Although more studies are needed to provide clear guidance on the opioid of choice, tapentadol shows some advantages, as it does not require CYP450 system activation and has minimal serotonergic effects. In addition, it leads to less side effects and lower abuse liability. However, invivo and invitro studies have shown that tramadol and tapentadol cause similar toxicological damage. In this context, it is important to underline that the choice of opioid should be individually balanced and a tailored decision, based on previous experience and on the patient's profile, type of pain and context of treatment. SignificanceThis review underlines the need for a careful prescription of tramadol and tapentadol. Although both are widely prescribed synthetic opioid analgesics, their toxic effects and potential dependence are not completely understood yet. In particular, concerning tapentadol, further research is needed to better assess its toxic effects.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 18